Los Angeles Capital Management LLC raised its holdings in shares of Enhabit, Inc. (NYSE:EHAB – Free Report) by 106.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 50,883 shares of the company’s stock after acquiring an additional 26,227 shares during the quarter. Los Angeles Capital Management LLC owned approximately 0.10% of Enhabit worth $402,000 as of its most recent SEC filing.
Several other large investors have also recently made changes to their positions in EHAB. Kent Lake Capital LLC bought a new stake in shares of Enhabit in the first quarter worth about $5,183,000. Marshall Wace LLP bought a new stake in shares of Enhabit in the second quarter worth about $1,941,000. DekaBank Deutsche Girozentrale increased its holdings in shares of Enhabit by 52.3% in the second quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company’s stock worth $4,306,000 after purchasing an additional 178,000 shares during the last quarter. WINTON GROUP Ltd bought a new stake in shares of Enhabit in the second quarter worth about $955,000. Finally, AREX Capital Management LP increased its stake in Enhabit by 2.5% during the second quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock worth $22,056,000 after acquiring an additional 59,353 shares during the last quarter.
Insiders Place Their Bets
In other Enhabit news, Director Jeffrey Bolton bought 5,000 shares of the company’s stock in a transaction on Thursday, August 22nd. The stock was acquired at an average price of $8.01 per share, for a total transaction of $40,050.00. Following the completion of the transaction, the director now directly owns 78,877 shares of the company’s stock, valued at approximately $631,804.77. This represents a 6.77 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.90% of the stock is currently owned by insiders.
Enhabit Trading Down 1.2 %
Enhabit (NYSE:EHAB – Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The company had revenue of $253.60 million for the quarter, compared to the consensus estimate of $261.69 million. During the same period in the previous year, the firm earned $0.03 earnings per share. As a group, research analysts expect that Enhabit, Inc. will post 0.25 EPS for the current year.
Enhabit Company Profile
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Further Reading
- Five stocks we like better than Enhabit
- Consumer Staples Stocks, Explained
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB – Free Report).
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.